TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
+3.73%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$28.3M
Cap. Flow
+$26.2M
Cap. Flow %
0.84%
Top 10 Hldgs %
33.83%
Holding
206
New
17
Increased
43
Reduced
39
Closed
34

Sector Composition

1 Healthcare 96.51%
2 Real Estate 2.72%
3 Industrials 0.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BPMC
176
DELISTED
Blueprint Medicines
BPMC
-122,699
Closed -$10.8M
CLDX icon
177
Celldex Therapeutics
CLDX
$1.52B
-7,053
Closed -$236K
CNC icon
178
Centene
CNC
$14.2B
-67,290
Closed -$4.91M
COGT icon
179
Cogent Biosciences
COGT
$1.82B
-537,742
Closed -$4.36M
EDIT icon
180
Editas Medicine
EDIT
$248M
-15,190
Closed -$860K
EXEL icon
181
Exelixis
EXEL
$10.2B
-499,657
Closed -$9.1M
GRFS icon
182
Grifois
GRFS
$6.89B
-47,373
Closed -$822K
INCY icon
183
Incyte
INCY
$16.9B
-107,687
Closed -$9.06M
INSM icon
184
Insmed
INSM
$30.7B
-98,387
Closed -$2.8M
IOVA icon
185
Iovance Biotherapeutics
IOVA
$901M
-468,538
Closed -$12.2M
MDGL icon
186
Madrigal Pharmaceuticals
MDGL
$9.65B
-13,340
Closed -$1.3M
NKTR icon
187
Nektar Therapeutics
NKTR
$764M
-12,029
Closed -$3.1M
OVID icon
188
Ovid Therapeutics
OVID
$87.5M
-372,733
Closed -$1.46M
PSNL icon
189
Personalis
PSNL
$465M
-179,731
Closed -$4.55M
REPL icon
190
Replimune Group
REPL
$494M
-219,060
Closed -$8.42M
RGNX icon
191
Regenxbio
RGNX
$490M
-21,700
Closed -$843K
SAGE
192
DELISTED
Sage Therapeutics
SAGE
-114,119
Closed -$6.48M
TFX icon
193
Teleflex
TFX
$5.78B
-2,200
Closed -$884K
YMAB icon
194
Y-mAbs Therapeutics
YMAB
$390M
-197,820
Closed -$6.69M
DCPH
195
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-307,703
Closed -$11.3M
CBAY
196
DELISTED
Cymabay Therapeutics
CBAY
-88,102
Closed -$384K
RETA
197
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-38,219
Closed -$5.41M
MTEM
198
DELISTED
Molecular Templates, Inc.
MTEM
-13,295
Closed -$1.56M
JNCE
199
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-382,237
Closed -$2.6M
DRNA
200
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-68,150
Closed -$2.54M